• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自杀失活揭示的LSD1介导组蛋白去甲基化的结构基础

Structural basis of histone demethylation by LSD1 revealed by suicide inactivation.

作者信息

Yang Maojun, Culhane Jeffrey C, Szewczuk Lawrence M, Gocke Christian B, Brautigam Chad A, Tomchick Diana R, Machius Mischa, Cole Philip A, Yu Hongtao

机构信息

Department of Pharmacology, The University of Texas Southwestern Medical Center, 6001 Forest Park Road, Dallas, Texas 75390, USA.

出版信息

Nat Struct Mol Biol. 2007 Jun;14(6):535-9. doi: 10.1038/nsmb1255. Epub 2007 May 27.

DOI:10.1038/nsmb1255
PMID:17529991
Abstract

Histone methylation regulates diverse chromatin-templated processes, including transcription. The recent discovery of the first histone lysine-specific demethylase (LSD1) has changed the long-held view that histone methylation is a permanent epigenetic mark. LSD1 is a flavin adenine dinucleotide (FAD)-dependent amine oxidase that demethylates histone H3 Lys4 (H3-K4). However, the mechanism by which LSD1 achieves its substrate specificity is unclear. We report the crystal structure of human LSD1 with a propargylamine-derivatized H3 peptide covalently tethered to FAD. H3 adopts three consecutive gamma-turns, enabling an ideal side chain spacing that places its N terminus into an anionic pocket and positions methyl-Lys4 near FAD for catalysis. The LSD1 active site cannot productively accommodate more than three residues on the N-terminal side of the methyllysine, explaining its H3-K4 specificity. The unusual backbone conformation of LSD1-bound H3 suggests a strategy for designing potent LSD1 inhibitors with therapeutic potential.

摘要

组蛋白甲基化调控多种以染色质为模板的过程,包括转录。首个组蛋白赖氨酸特异性去甲基化酶(LSD1)的近期发现,改变了长期以来认为组蛋白甲基化是一种永久性表观遗传标记的观点。LSD1是一种依赖黄素腺嘌呤二核苷酸(FAD)的胺氧化酶,可使组蛋白H3赖氨酸4(H3-K4)去甲基化。然而,LSD1实现其底物特异性的机制尚不清楚。我们报道了人LSD1与炔丙胺衍生化的H3肽共价连接到FAD的晶体结构。H3采用三个连续γ转角,实现理想的侧链间距,使其N端进入一个阴离子口袋,并将甲基化的赖氨酸4定位在FAD附近以便催化。LSD1活性位点无法有效容纳甲基赖氨酸N端一侧超过三个残基,这解释了其对H3-K4的特异性。与LSD1结合的H3的异常主链构象提示了一种设计具有治疗潜力的强效LSD1抑制剂的策略。

相似文献

1
Structural basis of histone demethylation by LSD1 revealed by suicide inactivation.自杀失活揭示的LSD1介导组蛋白去甲基化的结构基础
Nat Struct Mol Biol. 2007 Jun;14(6):535-9. doi: 10.1038/nsmb1255. Epub 2007 May 27.
2
Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine.抗抑郁药反式-2-苯基环丙胺抑制LSD1组蛋白去甲基化酶的结构基础
Biochemistry. 2007 Jul 10;46(27):8058-65. doi: 10.1021/bi700664y. Epub 2007 Jun 15.
3
Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase.人类LSD1组蛋白去甲基化酶对核小体进行CoREST依赖性去甲基化的结构基础。
Mol Cell. 2006 Aug 4;23(3):377-87. doi: 10.1016/j.molcel.2006.07.012.
4
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.由核胺氧化酶同源物LSD1介导的组蛋白去甲基化作用
Cell. 2004 Dec 29;119(7):941-53. doi: 10.1016/j.cell.2004.12.012.
5
Crystal structure and mechanism of human lysine-specific demethylase-1.人类赖氨酸特异性去甲基化酶-1的晶体结构与作用机制
Nat Struct Mol Biol. 2006 Jul;13(7):626-32. doi: 10.1038/nsmb1113. Epub 2006 Jun 25.
6
Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A.组蛋白去甲基化酶LSD1与反苯环丙胺在2.25埃分辨率下的晶体结构。
Biochem Biophys Res Commun. 2008 Feb 1;366(1):15-22. doi: 10.1016/j.bbrc.2007.11.066. Epub 2007 Nov 26.
7
New roles of flavoproteins in molecular cell biology: histone demethylase LSD1 and chromatin.黄素蛋白在分子细胞生物学中的新作用:组蛋白去甲基化酶LSD1与染色质
FEBS J. 2009 Aug;276(16):4304-12. doi: 10.1111/j.1742-4658.2009.07142.x. Epub 2009 Jul 14.
8
Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process.由赖氨酸特异性去甲基化酶1(LSD1)催化的组蛋白去甲基化是一个黄素依赖性氧化过程。
FEBS Lett. 2005 Apr 11;579(10):2203-7. doi: 10.1016/j.febslet.2005.03.015.
9
Solution structure of the SWIRM domain of human histone demethylase LSD1.人类组蛋白去甲基化酶LSD1的SWIRM结构域的溶液结构
Structure. 2006 Mar;14(3):457-68. doi: 10.1016/j.str.2005.12.004.
10
Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.未甲基化组蛋白H3赖氨酸4的识别将BHC80与LSD1介导的基因抑制联系起来。
Nature. 2007 Aug 9;448(7154):718-22. doi: 10.1038/nature06034.

引用本文的文献

1
Biochemical, structural, and cellular characterization of S-but-3-yn-2-ylglycine as a mechanism-based covalent inactivator of the flavoenzyme proline dehydrogenase.S-丁-3-炔-2-基甘氨酸作为黄素酶脯氨酸脱氢酶基于机制的共价失活剂的生化、结构和细胞表征
Arch Biochem Biophys. 2025 Mar;765:110319. doi: 10.1016/j.abb.2025.110319. Epub 2025 Jan 25.
2
Mechanism of ultrafast flavin photoreduction in the active site of flavoenzyme LSD1 histone demethylase.黄素酶LSD1组蛋白去甲基化酶活性位点中超快黄素光还原的机制。
Chem Sci. 2024 Nov 25;16(1):338-344. doi: 10.1039/d4sc06857b. eCollection 2024 Dec 18.
3
Uncoupling histone modification crosstalk by engineering lysine demethylase LSD1.
通过工程化赖氨酸脱甲基酶LSD1来解开组蛋白修饰的串扰。
Nat Chem Biol. 2025 Feb;21(2):227-237. doi: 10.1038/s41589-024-01671-9. Epub 2024 Jul 4.
4
Strategies that regulate LSD1 for novel therapeutics.用于新型疗法的调控赖氨酸特异性去甲基化酶1的策略。
Acta Pharm Sin B. 2024 Apr;14(4):1494-1507. doi: 10.1016/j.apsb.2024.01.005. Epub 2024 Jan 10.
5
Epigenetic modifications in the development of bronchopulmonary dysplasia: a review.支气管肺发育不良的发生发展中的表观遗传修饰:综述。
Pediatr Res. 2024 Aug;96(3):632-642. doi: 10.1038/s41390-024-03167-7. Epub 2024 Apr 3.
6
The Cross-Regulation Between Set1, Clr4, and Lsd1/2 in Schizosaccharomyces pombe.《裂殖酵母 Set1、Clr4 和 LSD1/2 之间的相互调控》
PLoS Genet. 2024 Jan 5;20(1):e1011107. doi: 10.1371/journal.pgen.1011107. eCollection 2024 Jan.
7
Relationship between histone demethylase LSD family and development and prognosis of gastric cancer.组蛋白去甲基化酶 LSD 家族与胃癌的发生发展及预后的关系。
Front Immunol. 2023 May 3;14:1170773. doi: 10.3389/fimmu.2023.1170773. eCollection 2023.
8
Targeting epigenetic regulators to overcome drug resistance in cancers.靶向表观遗传调控因子以克服癌症中的耐药性。
Signal Transduct Target Ther. 2023 Feb 17;8(1):69. doi: 10.1038/s41392-023-01341-7.
9
Determination of Multidirectional Pathways for Ligand Release from the Receptor: A New Approach Based on Differential Evolution.从受体上确定配体释放的多向途径:一种基于差分进化的新方法。
J Chem Theory Comput. 2022 Jun 14;18(6):3860-3872. doi: 10.1021/acs.jctc.1c01158. Epub 2022 May 5.
10
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity.含杂环的曲马普汀衍生物具有高 LSD1 抑制活性。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):973-985. doi: 10.1080/14756366.2022.2052869.